Assessment of plasma fibronectin concentration in type 1 diabetic patients;Ocena stȩżenia fibronektyny w osoczu u chorych z typem 1 cukrzycy

Polskie Archiwum Medycyny Wewnetrznej

Volumn 102, Issue 3, 1999, Pages 773-777

  Zozulińska, Dorota ^a   Derc, Katarzyna ^a   Majchrzak, Anna ^a   Szczepanik, Adam ^b   Wierusz Wysocka, Bogna ^a  

^a Oddział Chorob W ^*

^b Klinika Intensywnej Terapii K   (Poland)

Author keywords

Fibronectin; Inflammatory process; Type 1 diabetes mellitus

Indexed keywords

FIBRONECTIN;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; FIBRONECTINS; HUMANS; MALE; MIDDLE AGED;

EID: 0033186524     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mosesson M.W., Amrani D.L.: The structure biologic activities of plasma fibronectin. Blood, 1980, 56, 145.
2. Ruoslahti E., Vaheri A.: Interaction of soluble fibroblast surface antigen with fibrinogen and fibrin. Identity with cold insoluble globulin of human plasma. J. Exp. Med., 1975, 141, 497.
3. Mosher D.F.: Crosslinking of cold-insoluble globulin by fibrin-stabilizing factor. J. Biol. Chem., 1975, 250, 6614.
4. Jakubowski A., Ehrenfels B.N., Pepinsky R.B., Burkly L.C.: Vascular cell adhesion molecule-Ig fusion protein selectively targets activated alpha 4-integrin receptors in vivo. Inhibition of autoimmune diabetes in an adoptive transfer model in nonobese diabetic mice. J. Immunol., 1995, 15, 938.
5. Mosher D.F.: Organisation of provisional fibronectin matrix: control by products of blood coagulation. Thromb. Haemost., 1995, 74, 529.
6. Ugarova T., Agbanyo F.R., Plow E.F.: Conformational changes in adhesive proteins modulate their function. Thromb. Haemost., 1995, 74, 253.
7. Kuusela P.: Fibronectin binds to Staphylococcus aureus. Nature, 1978, 276, 718.
8. Tooke J.E.: Mikrokra̧żenie u chorych na cukrzycȩ. Medicographia, 1998, 8, 80.
9. Bek T., Ledet T.: Glicoprotein deposition in vascular walls of diabetic retinopathy. A histopatological and immunohistochemical study. Acta Ophtalmol. Scand., 1996, 754, 385.
10. Lee I.K., Park K.Y., Oh H.K., Park R.W., Jo J.S.: Plasma type IV collagen and fibronectin concentration in diabetic patients with microangiopathy. J. Korean. Med. Sci., 1994, 9, 341.
11. De Giorgio L.A., Bartolomei G., Gironi A., Caselli P., Seghieri G.: Increased plasma fibronectin concentration in diabetic patients with microalbuminuria. Diabetes care, 1988, 11, 527.
12. Ozata M., Kurt I., Azal O. i wsp.: Can we use plasma fibronectin levels as a marker for early diabetic nephropathy. Endocr. J., 1995, 42, 301.
13. De-Meyer G.R., Herman A.G.: Vascular endothelial dysfunction. Prog. Cardiovasc. Dis., 1997, 39 (4), 325.
14. Zozulińska D., Sobieska M., Wiktorowicz K., Wierusz-Wysocka B.: Levels of serum cell adhesion molecules in type I diabetic patients with microangiopathy. Diabetologia, 1999, 42 (suppl. 1), A319.
15. Lee T.S., MacGregor L.C., Fluharty J.J.H., King G.L.: Differential regulation of protein kinase C and Na, K-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. J. Clin. Invest., 1989, 83, 90.
16. Dunlop M.E., Clark S., Mahadevan P., Muggli E., Larkins R.G.: Production of hyaluronan by glomerular mesangial cells in response to fibronectin and platelet derived growth factor. Kidney Int., 1996, 50, 40.